Heterocyclic selenamonophosphites protected on a hydroxyl group and processes for preparation thereof

US10100071B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10100071-B2
Application numberUS-201615370437-A
CountryUS
Kind codeB2
Filing dateDec 6, 2016
Priority dateDec 7, 2015
Publication dateOct 16, 2018
Grant dateOct 16, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Novel heterocyclic selenamonophosphites protected on the hydroxyl group, processes for preparation thereof and the use thereof as ligand.

First claim

Opening claim text (preview).

The invention claimed is: 1. A heterocyclic selenaphosphite compound having a general structure (I) where R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently selected from: —H, —(C 1 -C 12 )-alkyl, —O—(C 1 -C 12 )-alkyl, —(C 6 -C 20 )-aryl, —O—(C 6 -C 20 )-aryl, -halogen, —OC═O—(C 1 -C 12 )-alkyl, —S-alkyl, —S-aryl, —COO—(C 1 -C 12 )-alkyl, —CONH—(C 1 -C 12 )-alkyl, —CO—(C 1 -C 12 )-alkyl, —CO—(C 6 -C 20 )-aryl, —COOH, —SO 3 H, —CN, or —N[(C 1 -C 12 )-alkyl] 2 , where the alkyl groups are linear, branched or cyclic, where the alkyl and aryl groups are each independently unsubstituted or substituted, where each substituted —(C 1 -C 12 )-alkyl group and substituted —(C 6 -C 20 )-aryl group have at least one substituent and the at least one substituent is each independently selected from —(C 3 -C 12 )-cycloalkyl, —(C 3 -C 12 )-heterocycloalkyl, —(C 6 -C 20 )-aryl, fluorine, chlorine, cyano, formyl, acyl, or alkoxycarbonyl, and where the —R 1 group is selected from: —(C 1 -C 12 )-alkyl, —(C 1 -C 12 )-alkyl-O—(C 1 -C 12 )-alkyl, —(C 6 -C 20 )-aryl, —(C 1 -C 12 )-alkyl-O—(C 6 -C 20 )-aryl, —(C 6 -C 20 )-aryl-O—(C 1 -C 12 )-alkyl, —(C 6 -C 20 )-aryl-O—(C 6 -C 20 )-aryl, —(C═O)—O—(C 1 -C 12 )-alkyl, -acetyl, where the alkyl groups are linear, branched or cyclic, where the alkyl and aryl groups mentioned are each independently unsubstituted or substituted, where substituted —(C 1 -C 12 )-alkyl groups and substituted —(C 6 -C 20 )-aryl groups have at least one substituent and the at least one substituent in each case is independently selected from —(C 3 -C 12 )-cycloalkyl, —(C 3 -C 12 )-heterocycloalkyl, —(C 6 -C 20 )-aryl, fluorine, chlorine, cyano, formyl, acyl, or alkoxycarbonyl, and the —R 1 * group is an organofunctional phosphite group. 2. The compound according to claim 1 , wherein in the heterocyclic selenaphosphite of the general structure (I) —R 1 * is an organofunctional phosphite group selected from the structures (II), (III), (IV, (V), (VI) and (VII) where the radicals R 15 , R 16 , R 17 , R 18 , R 19 , R 20 , R 21 , R 22 in structure (II), R 10 , R 11 , R 12 , R 13 , R 14 , R 10 *, R 11 *, R 12 *, R 13 *, R 14 * in the structure (III), R 23 , R 24 , R 25 , R 26 , R 27 , R 28 , R 29 , R 30 , R 31 , and R 32 in structure (IV), R 43 , R 44 , R 45 , R 46 , R 47 , R 48 , R 49 , R 50 , R 51 , R 52 , R 53 and R 54 in structure (V), and R 55 , R 56 , R 57 , R 58 , R 59 and R 60 in structure (VII). in each case in the respective structure are independently selected from: —H, —(C 1 -C 12 )-alkyl, —O—(C 1 -C 12 )-alkyl, —(C 6 -C 20 )-aryl, —O—(C 6 -C 20 )-aryl, or -halogen, where the alkyl groups are linear, branched or cyclic, where the alkyl and aryl groups are each independently unsubstituted or substituted, where each substituted —(C 1 -C 12 )-alkyl group and each substituted —(C 6 -C 20 )-aryl group has at least one substituent and the at least one substituent in each case is independently selected from —(C 3 C 12 )-cycloalkyl, —(C 3 -C 12 )-heterocycloalkyl, —(C 6 -C 20 )-aryl, fluorine, chlorine, cyano, formyl, acyl or alkoxycarbonyl. 3. The compound according to claim 1 , wherein the —R 1 group in the structure (I) is selected from: —(C 1 -C 12 )-alkyl, —(C 1 -C 12 )-alkyl-O—(C 1 -C 12 )-alkyl, —(C 6 -C 20 )-aryl, —(C 6 -C 20 )-aryl-O—(C 1 -C 12 )alkyl, —(C 1 -C 12 )-alkyl-O—(C 6 -C 20 )-aryl, —(C 6 -C 20 )-aryl-O—(C 6 -C 20 )-aryl, —(C═O)—O—(C 1 -C 12 )-alkyl, where the alkyl groups are linear, branched or cyclic, where the alkyl and aryl groups mentioned are each independently unsubstituted or substituted, where substituted —(C 1 -C 12 )-alkyl groups and substituted —(C 6 -C 20 )-aryl groups have at least one substituent and the at least one substituent in each case is independently selected from —(C 3 -C 12 )-cycloalkyl and/or —(C 6 -C 20 )-aryl. 4. The compound according to claim 1 , wherein the heterocyclic selenaphosphite of the general structure (I) is compound of structure (Ia) where R 2 , R 4 , R 7 and R 9 are each independently selected from: —(C 1 -C 12 )-alkyl, —O—(C 1 -C 12 )-alkyl, —(C 6 -C 20 )-aryl, —O—(C 6 -C 20 )-aryl, or -halogen, where the alkyl groups are linear, branched or cyclic, where the —R 1 group is selected from: —(C 1 -C 12 )-alkyl, —(C 1 -C 12 )-alkyl-O—(C 1 -C 12 )-alkyl, —(C 6 -C 20 )-aryl, —(C 1 -C 12 )-alkyl-O—(C 6 -C 20 )-aryl, —(C 6 -C 20 )-aryl-O—(C 1 -C 12 )-alkyl, or —(C 6 -C 20 )-aryl-O—(C 6 -C 20 )-aryl, where the alkyl groups are linear, branched or cyclic, and the —R 1 * group in structure (Ia) is an organofunctional phosphite group. 5. The compound according to claim 4 , wherein the —R 1 * in the heterocyclic selenaphosphite of the structure (Ia) is selected from the structures (II), (III), (IV), (V), (VI) and (VII) where the radicals R 15 , R 16 , R 17 , R 18 , R 19 , R 20 , R 21 , R 22 in structure (II), R 10 , R 11 , R 12 , R 13 , R 14 , R 10 *, R 11 *, R 12 *, R 13 *, R 14 * in the structure (III), R 23 , R 24 , R 25 , R 26 , R 27 , R 28 , R 29 , R 30 , R 31 , and R 32 in structure (IV), R 43 , R 44 , R 45 , R 46 , R 47 , R 48 , R 49 , R 50 , R 51 , R 52 , R 53 and R 54 in structure (V), and R 55 , R 56 , R 57 , R 58 , R 59 and R 60 in structure (VII), in each case for each structure are independently selected from: —H, —(C 1 -C 12 )-alkyl, —O—(C 1 -C 12 )-alkyl, —(C 6 -C 20 )-aryl, —O—(C 6 -C 20 )-aryl, or -halogen, where the alkyl groups are linear, branched or cyclic. 6. The compound according to claim 4 , wherein the —R 1 * in the heterocyclic selenaphosphite of the structure (Ia) is selected from structure (III) and the —R 1 group is selected from —(C 1 -C 12 )-alkyl, —(C 1 -C 12 )-alkyl-O—(C 1 -C 12 )-alkyl, —(C 6 -C 20 )-aryl, —(C 1 -C 12 )-alkyl-O—(C 6 -C 20 )-aryl, —(C 6 -C 20 )-aryl-O—(C 1 -C 12 )-alkyl, or —(C 6 -C 20 )-aryl-O—(C 6 -C 20 )-aryl, where the alkyl groups are linear, branched or cyclic, where R 2 , R 4 , R 7 and R 9 in structure (Ia) are each independently selected from —(C 1 -C 12 )-alkyl, or —O—(C 1 -C 12 )-alkyl, where the alkyl groups are linear, branched or cyclic, and with R 10 , R 11 , R 12 , R 13 , R 14 , R 10 *, R 11 *, R 12 *, R 13 *, R 14 * in the structure (III) each independently selected from: —H, —(C 1 -C 12 )-alkyl, —O—(C 1 -C 12 )-alkyl, where the alkyl groups are linear, branched or cyclic. 7. A rhodium hydroformylation catalyst, comprising: the compound according to claim 1 as a ligand. 8. A process for preparing at least one heterocyclic selenephosphite of the general structure (I) where R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently selected from: —H, —(C 1 -C 12 )-alkyl, —O—(C 1 -C 12 )-alkyl, —(C 6 -C 20 )-aryl, —O—(C 6 -C 20 )-aryl, -halogen, —OC═O—(C 1 -C 12 )-alkyl, —S-alkyl, —S-aryl, —

Assignees

Inventors

Classifications

  • having selenium atoms bound to carbon atoms of six-membered aromatic rings · CPC title

  • condensed with carbocyclic rings or carbocyclic ring systems · CPC title

  • condensed with carbocyclic rings or carbocyclic ring systems · CPC title

  • condensed with carbocyclic or heterocyclic rings or ring systems · CPC title

  • condensed with carbocyclic rings or carbocyclic ring systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10100071B2 cover?
Novel heterocyclic selenamonophosphites protected on the hydroxyl group, processes for preparation thereof and the use thereof as ligand.
Who is the assignee on this patent?
Evonik Degussa Gmbh
What technology area does this patent fall under?
Primary CPC classification C07F9/65527. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).